Cme (CME) Cash from Investing Activities (2010 - 2026)

Cme (CME) has reported Cash from Investing Activities for 17 consecutive years, with -$29.4 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 63.33% year-over-year to -$29.4 million; the TTM figure through Jun 2026 stood at $1.5 billion (up 1767.12% YoY), while the FY2025 annual figure was $1.5 billion, up 1914.53% from the prior year.
• Cash from Investing Activities declined to -$29.4 million in Q2 2026 per CME's latest filing, from -$23.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.6 billion in Q4 2025 and bottomed at -$417.6 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged $49.7 million across 5 years, with a median of -$21.6 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 1128.24% — and 2025, when it jumped 6233.99%.
• Cme's Cash from Investing Activities stood at -$25.7 million in 2022, then advanced by 20.62% to -$20.4 million in 2023, then decreased by 24.02% to -$25.3 million in 2024, then surged by 6233.99% to $1.6 billion in 2025, then tumbled by 101.89% to -$29.4 million in 2026.
• Business Quant data shows CME's Cash from Investing Activities at -$29.4 million in Q2 2026, -$23.0 million in Q1 2026, and $1.6 billion in Q4 2025.